Effects of endurance training on skeletal muscle oxidative capacities with and without selenium supplementation.
The purpose of this study was to examine the changes induced by endurance training, with or without selenium (Se) supplementation on: 1) mitochondrial activity of succinate dehydrogenase (SDH) and cytochrome c oxidase (Cyt Ox),2) the myosin heavy chain (MHC) expression in muscle fibers and 3) their association with aerobic performance. Twenty-four male students volunteered to participate in this double blind study: selenium (Sel, N = 12) vs placebo (Pla, N = 12). During a 10-wk endurance training program, the Sel group received a daily Se supplementation containing 180 micrograms of organic selenium (selenomethionine), while the Pla group received a placebo. Before (Pre) and after (Post) the program (3 sessions wk-1) an endurance exercise (Capmax) was performed in order to determine the aerobic endurance capacity assessed by the total oxygen uptake during the running test (VO2tot). All parameters of aerobic performance were increased in both groups, concomitantly to a rise in mitochondrial Cyt Ox activity. Two positive relationships were found: 1) between type I MHC and VO2tot increments (r = 0.65, P < 0.05), 2) between training volumes and VO2tot increments (r = 0.53, P < 0.05; N = 23). The training program produced an 8.2% significant increase in type I MHC (P < 0.05) while type II MHC decrease was not significant (-4.4%). Although they were almost non-existent before the program, muscle fibers which co-expressed type I and II MHC displayed a marked increase afterwards (4.9 +/- 5.7 vs 1.1 +/- 2.1%, P < 0.05). Muscle GSH-Px activity, at rest, did not respond to endurance training or Se supplementation. The results suggest that the neuromuscular system is still in an evolutive state after 10 weeks of endurance training, and that selenium supplementation has no effect on endurance training-induced adaptations.
Margaritis
I
I
Laboratoire de Biomécanique et Biologie de l'Exercice, Faculté des Sciences du Sport, Université de Nice Sophia-Antipolis, France.
Tessier
F
F
Prou
E
E
Marconnet
P
P
Marini
J F
JF
D000328:Adult; D000704:Analysis of Variance; D003402:Creatine Kinase / Q000378:metabolism; D004311:Double-Blind Method; D003576:Electron Transport Complex IV / Q000378:metabolism; D019085:Fluorescent Antibody Technique, Direct; D005979:Glutathione Peroxidase / Q000378:metabolism; D006801:Humans; D008297:Male; D008931:Mitochondria, Muscle / Q000201:enzymology; D018485:Muscle Fibers, Skeletal / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D018995:Myosin Heavy Chains / Q000096:biosynthesis; D010101:Oxygen Consumption / Q000187:drug effects*; D010807:Physical Endurance / Q000502:physiology*; D010809:Physical Fitness; D010919:Placebos; D012643:Selenium / Q000008:administration & dosage / Q000494:pharmacology*; D013385:Succinate Dehydrogenase / Q000378:metabolism; D014810:Vitamin E / Q000097:blood
D010919:Placebos; D014810:Vitamin E; D005979:Glutathione Peroxidase; D013385:Succinate Dehydrogenase; D003576:Electron Transport Complex IV; D003402:Creatine Kinase; D018995:Myosin Heavy Chains; D012643:Selenium